Skip to main content

MoneyWorks4Me

Sun Pharmaceutical Industries informs about press release

07 Apr 2025 Evaluate
Sun Pharmaceutical Industries has informed that it enclosed a copy of the Press Release about Sun Pharma introducing a novel class of drug, Fexuclue®(Fexuprazan) in India for the treatment of Erosive Esophagitis, which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..